Kurt W. Vogel

1.2k total citations
36 papers, 909 citations indexed

About

Kurt W. Vogel is a scholar working on Molecular Biology, Oncology and Biophysics. According to data from OpenAlex, Kurt W. Vogel has authored 36 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Biophysics. Recurrent topics in Kurt W. Vogel's work include Neurological diseases and metabolism (5 papers), Metabolism and Genetic Disorders (4 papers) and Advanced Fluorescence Microscopy Techniques (4 papers). Kurt W. Vogel is often cited by papers focused on Neurological diseases and metabolism (5 papers), Metabolism and Genetic Disorders (4 papers) and Advanced Fluorescence Microscopy Techniques (4 papers). Kurt W. Vogel collaborates with scholars based in United States, Norway and Switzerland. Kurt W. Vogel's co-authors include Dale G. Drueckhammer, Steven M. Riddle, Robert A. Horton, Connie S. Lebakken, Christopher T. Walsh, T. Tao, Max M. Burger, Ralph H. Lambalot, Alex Matter and Amy M. Gehring and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and PLoS ONE.

In The Last Decade

Kurt W. Vogel

36 papers receiving 861 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kurt W. Vogel United States 17 628 168 122 115 104 36 909
Takuya Furuta Japan 22 719 1.1× 272 1.6× 102 0.8× 268 2.3× 99 1.0× 101 1.7k
Steven M. Riddle United States 14 858 1.4× 254 1.5× 170 1.4× 69 0.6× 145 1.4× 19 1.1k
Gabriela E. Davey Switzerland 13 668 1.1× 336 2.0× 31 0.3× 204 1.8× 100 1.0× 15 1.1k
A.B. Soriaga United States 8 1.2k 1.9× 185 1.1× 111 0.9× 41 0.4× 86 0.8× 10 1.6k
Elena Ardini Italy 21 1.0k 1.6× 537 3.2× 83 0.7× 211 1.8× 113 1.1× 38 1.6k
Laura Silvian United States 18 1.0k 1.6× 138 0.8× 39 0.3× 116 1.0× 48 0.5× 31 1.4k
Jacky Chi Ki Ngo Hong Kong 19 893 1.4× 81 0.5× 47 0.4× 64 0.6× 90 0.9× 45 1.2k
Gianpaolo Fogliatto Italy 7 518 0.8× 128 0.8× 52 0.4× 100 0.9× 24 0.2× 9 761
Qingkai Yang China 21 1.3k 2.1× 310 1.8× 268 2.2× 135 1.2× 232 2.2× 37 1.7k
Bainan Wu United States 22 880 1.4× 244 1.5× 30 0.2× 150 1.3× 87 0.8× 28 1.2k

Countries citing papers authored by Kurt W. Vogel

Since Specialization
Citations

This map shows the geographic impact of Kurt W. Vogel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt W. Vogel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt W. Vogel more than expected).

Fields of papers citing papers by Kurt W. Vogel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt W. Vogel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt W. Vogel. The network helps show where Kurt W. Vogel may publish in the future.

Co-authorship network of co-authors of Kurt W. Vogel

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt W. Vogel. A scholar is included among the top collaborators of Kurt W. Vogel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt W. Vogel. Kurt W. Vogel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Hare, Thomas, Christopher A. Eide, Anupriya Agarwal, et al.. (2013). Threshold Levels of ABL Tyrosine Kinase Inhibitors Retained in Chronic Myeloid Leukemia Cells Determine Their Commitment to Apoptosis. Cancer Research. 73(11). 3356–3370. 23 indexed citations
2.
Hermanson, Spencer, Coby B. Carlson, Steven M. Riddle, et al.. (2012). Screening for Novel LRRK2 Inhibitors Using a High-Throughput TR-FRET Cellular Assay for LRRK2 Ser935 Phosphorylation. PLoS ONE. 7(8). e43580–e43580. 32 indexed citations
3.
Bi, Kun, Connie S. Lebakken, & Kurt W. Vogel. (2011). Transformation ofin vitrotools for kinase profiling: keeping an eye over the off-target liabilities. Expert Opinion on Drug Discovery. 6(7). 701–712. 6 indexed citations
4.
Huwiler, Kristin G., et al.. (2010). A Fluorescence Anisotropy Assay for the Muscarinic M1 G-protein-Coupled Receptor. Assay and Drug Development Technologies. 8(3). 351–361. 18 indexed citations
5.
Carlson, Coby B., Robert A. Horton, & Kurt W. Vogel. (2009). A Toolbox Approach to High-Throughput TR-FRET-Based SUMOylation and DeSUMOylation Assays. Assay and Drug Development Technologies. 832821993–8. 2 indexed citations
6.
Lebakken, Connie S., Steven M. Riddle, Upinder Singh, et al.. (2009). Development and Applications of a Broad-Coverage, TR-FRET-Based Kinase Binding Assay Platform. SLAS DISCOVERY. 14(8). 924–935. 68 indexed citations
7.
Reichling, Laurie J., et al.. (2008). Pharmacological Characterization of Purified Recombinant mTOR FRB-Kinase Domain Using Fluorescence-Based Assays. SLAS DISCOVERY. 13(3). 238–244. 2 indexed citations
8.
Gao, Yi, et al.. (2008). Biochemical assays for selectivity profiling across the entire PI3 kinase family. Cancer Research. 68. 1 indexed citations
9.
Reichling, Laurie J., Steven M. Riddle, Baigen Mei, et al.. (2008). Homogenous Fluorescent Assays for Characterizing Small-Molecule Activators of AMP-Activated Protein Kinase (AMPK). PubMed. 1. 34–42. 2 indexed citations
10.
Kupcho, Kevin R., et al.. (2008). Fluorescent Cascade and Direct Assays for Characterization of RAF Signaling Pathway Inhibitors. PubMed. 1. 43–53. 9 indexed citations
11.
Piper, David R., William J. Frazee, Elizabeth A. Frey, et al.. (2008). Development of the Predictor hERG Fluorescence Polarization Assay Using a Membrane Protein Enrichment Approach. Assay and Drug Development Technologies. 6(2). 213–223. 37 indexed citations
12.
Robers, Matthew B., et al.. (2007). High-throughput cellular assays for regulated posttranslational modifications. Analytical Biochemistry. 372(2). 189–197. 27 indexed citations
13.
Lebakken, Connie S., Hee Chol Kang, & Kurt W. Vogel. (2007). A Fluorescence Lifetime–Based Binding Assay to Characterize Kinase Inhibitors. SLAS DISCOVERY. 12(6). 828–841. 34 indexed citations
14.
Horton, Robert A., et al.. (2006). A substrate for deubiquitinating enzymes based on time-resolved fluorescence resonance energy transfer between terbium and yellow fluorescent protein. Analytical Biochemistry. 360(1). 138–143. 38 indexed citations
15.
Vogel, Kurt W., et al.. (2006). Improving Lanthanide-Based Resonance Energy Transfer Detection by Increasing Donor-Acceptor Distances. SLAS DISCOVERY. 11(4). 439–443. 17 indexed citations
16.
Marks, Bryan D., et al.. (2005). Multiparameter Analysis of a Screen for Progesterone Receptor Ligands: Comparing Fluorescence Lifetime and Fluorescence Polarization Measurements. Assay and Drug Development Technologies. 3(6). 613–622. 16 indexed citations
17.
Hoffman, Randy, et al.. (2004). Overcoming Compound Interference in Fluorescence Polarization-Based Kinase Assays Using Far-Red Tracers. Assay and Drug Development Technologies. 2(2). 193–203. 48 indexed citations
18.
Blommel, Paul G., George T. Hanson, & Kurt W. Vogel. (2004). Multiplexing Fluorescence Polarization Assays to Increase Information Content Per Screen: Applications for Screening Steroid Hormone Receptors. SLAS DISCOVERY. 9(4). 294–302. 15 indexed citations
19.
Huang, Haidong, et al.. (2004). The importance of the amide bond nearest the thiol group in enzymatic reactions of coenzyme A. Bioorganic Chemistry. 33(2). 90–107. 7 indexed citations
20.
Beaman, Todd W., Kurt W. Vogel, Dale G. Drueckhammer, John S. Blanchard, & Steven L. Roderick. (2002). Acyl group specificity at the active site of tetrahydridipicolinate N‐succinyltransferase. Protein Science. 11(4). 974–979. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takuya Furuta Breakdown of academic impact, for papers by Steven M. Riddle Breakdown of academic impact, for papers by Gabriela E. Davey Breakdown of academic impact, for papers by A.B. Soriaga Breakdown of academic impact, for papers by Elena Ardini Breakdown of academic impact, for papers by Laura Silvian Breakdown of academic impact, for papers by Jacky Chi Ki Ngo Breakdown of academic impact, for papers by Gianpaolo Fogliatto Breakdown of academic impact, for papers by Qingkai Yang Breakdown of academic impact, for papers by Bainan Wu
Rankless by CCL
2026